Treatment with hyperimmune intravenous immunoglobulin (H-IVIG), derived from convalescent
plasma from patients recovered from H1N1 2009 influenza A infection, for patients with severe
H1N1 2009 infection will decrease mortality, reduce viral load, and shorten the length of
stay in ICU and hospital.
Phase:
N/A
Details
Lead Sponsor:
The University of Hong Kong
Collaborators:
Caritas Medical Centre, Hong Kong HK Red Cross Blood Transfusion Service, Hong Kong Pamela Youde Nethersole Eastern Hospital Queen Elizabeth Hospital, Hong Kong Queen Mary Hospital, Hong Kong Research Fund for the Control of Infectious Diseases, Hong Kong Ruttonjee Hospital, Hong Kong United Christian Hospital